Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 28, 2015 12:48 PM ET


Company Overview of Adamas Pharmaceuticals, Inc.

Key Executives for Adamas Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gregory T. Went Ph.D.33 RelationshipsChairman and Chief Executive Officer50
William J. Dawson 6 RelationshipsChief Financial Officer59
Jeffrey H. Knapp No RelationshipsChief Operating Officer and Chief Commercial Officer48
David N. Chernoff M.D.49 RelationshipsActing Chief Medical Officer--
Natalie L. McClure Ph.D.No RelationshipsSenior Vice President of Product Development61

Adamas Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gregory T. Went Ph.D. 33 RelationshipsAdamas Pharmaceuticals, Inc.50
David L. Mahoney 49 RelationshipsAdamas Pharmaceuticals, Inc.60
Richard H. Booth CPA, CLU, ChFC 101 Relationships1347 Capital Corp.67
Martha J. Demski 54 RelationshipsAjinomoto Althea, Inc.61
William W. Ericson J.D. 147 RelationshipsMohr Davidow Ventures55
View All Board Members

Adamas Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Martha J. Demski54 Relationships1 Executives
Compensation Committee CPA, CLU, ChFCRichard H. Booth101 Relationships2 Executives
Nominating Committee David L. Mahoney49 Relationships1 Executives
Corporate Governance Committee David L. Mahoney49 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$728.0K
Compensation as of Fiscal Year 2013
Adamas Pharmaceuticals, Inc. CEO Compensation
Industry Average


EMS Find, Inc. Announces Board Changes
March 26, 2015 9:25 PM ET
WD-40 Company Appoints Melissa Claassen to Board of Directors; Declares Regular Quarterly Dividend, Payable on April 30, 2015
March 24, 2015 3:47 PM ET
ZIL Limited Announces Board Changes
March 17, 2015 10:42 AM ET
Colgate-Palmolive Announces Board Changes
March 13, 2015 1:00 PM ET
Eveready Industries India Limited Announces the Demise of Deepak Khaitan, Vice-Chairman and Non- Executive Director
March 09, 2015 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adamas Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at